Exact Mass: 745.6223166
Exact Mass Matches: 745.6223166
Found 500 metabolites which its exact mass value is equals to given mass value 745.6223166,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PC(16:0/P-18:0)
C42H84NO7P (745.5985083999999)
PC(16:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/P-18:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.
PC(18:0/P-16:0)
C42H84NO7P (745.5985083999999)
PC(18:0/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/P-16:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.
PC(P-16:0/18:0)
C42H84NO7P (745.5985083999999)
PC(P-16:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/18:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-16:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/18:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(P-18:0/16:0)
C42H84NO7P (745.5985083999999)
PC(P-18:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/16:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of palmitic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/16:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of palmitic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(O-16:1(9Z)/18:0)
C42H84NO7P (745.5985083999999)
PC(O-16:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-16:1(9Z)/18:0), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of stearic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-16:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:1(9Z)/18:0), in particular, consists of one chain of Palmitoleyl alcohol at the C-1 position and one chain of stearic acid at the C-2 position. The Palmitoleyl alcohol moiety is derived from whale oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(O-18:1(11Z)/16:0)
C42H84NO7P (745.5985083999999)
PC(O-18:1(11Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(11Z)/16:0), in particular, consists of one chain of Vaccenyl alcohol at the C-1 position and one chain of palmitic acid at the C-2 position. The Vaccenyl alcohol moiety is derived from beef fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:1(11Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(11Z)/16:0), in particular, consists of one chain of Vaccenyl alcohol at the C-1 position and one chain of palmitic acid at the C-2 position. The Vaccenyl alcohol moiety is derived from beef fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(O-18:1(9Z)/16:0)
C42H84NO7P (745.5985083999999)
PC(O-18:1(9Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(9Z)/16:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of palmitic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:1(9Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/16:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of palmitic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
Phosphatidylcholine alkyl 18:1-16:0
C42H84NO7P (745.5985083999999)
Phosphatidylcholine alkyl 16:0-18:1
C42H84NO7P (745.5985083999999)
1-O-Hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
C42H84NO7P (745.5985083999999)
1-beta-D-galactopyranosyloxy-(2S,3R)-2-((2R)-2-hydroxyoctadecanoylamino)octadecan-3-ol
PC(O-18:1/16:0)
C42H84NO7P (745.5985083999999)
PC(O-18:1/16:0)[U]
C42H84NO7P (745.5985083999999)
PC(O-16:0/18:1)
C42H84NO7P (745.5985083999999)
PC(O-16:0/18:1)[U]
C42H84NO7P (745.5985083999999)
PC(O-16:0/18:1)[S]
C42H84NO7P (745.5985083999999)
PC(O-18:0/16:1)
C42H84NO7P (745.5985083999999)
PC(O-20:0/14:1(9Z))
C42H84NO7P (745.5985083999999)
PC(P-20:0/14:0)
C42H84NO7P (745.5985083999999)
PE(O-18:0/19:1(9Z))
C42H84NO7P (745.5985083999999)
PE(O-20:0/17:1(9Z))
C42H84NO7P (745.5985083999999)
PE(P-16:0/21:0)
C42H84NO7P (745.5985083999999)
PE(P-18:0/19:0)
C42H84NO7P (745.5985083999999)
PE(P-20:0/17:0)
C42H84NO7P (745.5985083999999)
PC O-34:1
C42H84NO7P (745.5985083999999)
PE O-37:1
C42H84NO7P (745.5985083999999)
1-HEXADECYL-2-OLEOYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE
C42H84NO7P (745.5985083999999)
A phosphatidylcholine (O-16:0/18:1) in which the alkyl and the acyl groups at positions 1 and 2 are hexadecyl and oleoyl respectively.
1-[(9Z)-octadecenyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine
C42H84NO7P (745.5985083999999)
A phosphatidylcholine O-34:1 in which the alkenyl group at position 1 is (9Z)-octadecenyl and the acyl group at position 2 is hexadecanoyl.
1-(1Z-octadecenyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine
C42H84NO7P (745.5985083999999)
A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alkenyl group at position 1 is (1Z)-octadecenyl and the acyl group at position 2 is hexadecanoyl respectively.
N-nonadecanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine
N-(2R-hydroxyoctadecanoyl)-1-beta-glucosyl-sphinganine
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(icosanoylamino)-15-methylhexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(nonadecanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
(15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxyoctan-2-yl)dotetraconta-15,18,21,24,27,30,33,36,39-nonaenamide
(18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]dotetraconta-18,21,24,27,30,33,36,39-octaenamide
[2-[(Z)-hexacos-15-enoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
(14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]dotriaconta-14,17,20,23,26,29-hexaenamide
(18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]hexatriaconta-18,21,24,27,30,33-hexaenamide
(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxytetradecan-2-yl)hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide
(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide
(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]tetratriaconta-13,16,19,22,25,28,31-heptaenamide
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctacosa-4,8,12-trien-2-yl]docosa-4,7,10,13,16,19-hexaenamide
(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E)-1,3-dihydroxytetracosa-4,8-dien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide
(15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]hexatriaconta-15,18,21,24,27,30,33-heptaenamide
(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexacosa-4,8,12-trien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide
(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(E)-1,3-dihydroxyicos-4-en-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide
(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]dotriaconta-11,14,17,20,23,26,29-heptaenamide
(12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]triaconta-12,15,18,21,24,27-hexaenamide
(8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxytetracosa-4,8,12-trien-2-yl]hexacosa-8,11,14,17,20,23-hexaenamide
(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide
(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E)-1,3-dihydroxydocosa-4,8-dien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide
(17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]octatriaconta-17,20,23,26,29,32,35-heptaenamide
(16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]tetratriaconta-16,19,22,25,28,31-hexaenamide
(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-(1,3-dihydroxydodecan-2-yl)octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide
(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-(1,3-dihydroxyoctadecan-2-yl)dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide
(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide
(16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]tetraconta-16,19,22,25,28,31,34,37-octaenamide
(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide
(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxydecan-2-yl)tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide
(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-(1,3-dihydroxyhexadecan-2-yl)tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide
(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]octatriaconta-14,17,20,23,26,29,32,35-octaenamide
(10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]octacosa-10,13,16,19,22,25-hexaenamide
3-Hydroxy-2-(2-hydroxytricosanoylamino)icosane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxytetracosanoylamino)nonadecane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxynonadecanoylamino)tetracosane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxyhenicosanoylamino)docosane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxypentacosanoylamino)octadecane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxyhexacosanoylamino)heptadecane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxyheptadecanoylamino)hexacosane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxyicosanoylamino)tricosane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
3-Hydroxy-2-(2-hydroxyoctadecanoylamino)pentacosane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] nonanoate
C42H84NO7P (745.5985083999999)
3-Hydroxy-2-(2-hydroxydocosanoylamino)henicosane-1-sulfonic acid
C43H87NO6S (745.6253761999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] (Z)-octacos-17-enoate
C42H84NO7P (745.5985083999999)
[3-[(Z)-hexacos-15-enoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-hexanoyloxy-3-[(Z)-octacos-17-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (Z)-icos-11-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (Z)-octadec-9-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (Z)-tetracos-13-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (Z)-pentadec-9-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] undecanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetracosoxypropan-2-yl] (Z)-tridec-9-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] hexadecanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] tridecanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] docosanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (Z)-heptadec-9-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (Z)-hexadec-9-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] heptadecanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (Z)-tetradec-9-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] tetracosanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] icosanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (Z)-hexacos-15-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] octadecanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (Z)-docos-13-enoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] pentadecanoate
C42H84NO7P (745.5985083999999)
[3-nonadecoxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-decoxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-henicosanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-henicosoxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-[(Z)-heptadec-9-enoyl]oxy-3-heptadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-[(Z)-icos-11-enoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-icosoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-[(Z)-docos-13-enoxy]-2-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-heptadecanoyloxy-3-[(Z)-heptadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-nonadecanoyloxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-[(Z)-henicos-11-enoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-decanoyloxy-3-[(Z)-tetracos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-[(Z)-nonadec-9-enoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-[(Z)-docos-13-enoyl]oxy-3-dodecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-[(Z)-henicos-11-enoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
N-(tetracosanoyl)-nonadecasphinganine-1-phosphate
C43H88NO6P (745.6348917999999)
N-(hexacosanoyl)-heptadecasphinganine-1-phosphate
C43H88NO6P (745.6348917999999)
{1-hexadecyl-2-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}choline
C42H84NO7P (745.5985083999999)
[2-hexadecanoyloxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] henicosanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] nonadecanoate
C42H84NO7P (745.5985083999999)
[2-[(Z)-icos-11-enoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-icosanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (Z)-nonadec-9-enoate
C42H84NO7P (745.5985083999999)
[3-[(Z)-hexadec-9-enoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[2-[(Z)-hexadec-9-enoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] tricosanoate
C42H84NO7P (745.5985083999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (Z)-henicos-11-enoate
C42H84NO7P (745.5985083999999)
2-[hydroxy-[(E)-3-hydroxy-2-(nonadecanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
[2-hexadecanoyloxy-3-[(Z)-octadec-4-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
[3-hexadecoxy-2-[(Z)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(octadecanoylamino)nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] nonadecanoate
C42H84NO7P (745.5985083999999)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tricosanoylamino)tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyhenicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2R,3S)-3-hydroxy-2-(nonadecanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(icosanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxyhenicos-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(heptadecanoylamino)-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(octadecanoylamino)nonadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tricosanoylamino)tetradec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(nonadecanoylamino)octadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(heptadecanoylamino)-3-hydroxyicos-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2S,3R)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
2-[[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxyhenicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(icosanoylamino)heptadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] henicosanoate
C42H84NO7P (745.5985083999999)
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] heptadecanoate
C42H84NO7P (745.5985083999999)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentadecanoylamino)docos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2S)-3-[(E)-icos-1-enoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
2-[[(E,2S,3R)-2-(docosanoylamino)-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(docosanoylamino)-3-hydroxypentadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentadecanoylamino)docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
[(2R)-3-[(E)-hexadec-1-enoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C42H84NO7P (745.5985083999999)
2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxyhexadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(dodecanoylamino)-3-hydroxypentacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tricosanoylamino)tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxypentacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(icosanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tridecanoylamino)tetracos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tricosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(heptadecanoylamino)-3-hydroxyicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-docos-11-enoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]docosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(octadecanoylamino)nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyhenicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tetradecanoylamino)tricos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(hexadecanoylamino)-3-hydroxyhenicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(henicosanoylamino)-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]tetracosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(docosanoylamino)-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(pentadecanoylamino)docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(hexanoylamino)-3-hydroxyhentriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(pentacosanoylamino)dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyhenicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(hexacosanoylamino)-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-acetamido-3-hydroxypentatriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(heptacosanoylamino)-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tetracosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)nonacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)octacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)tetratriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxypentadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(nonacosanoylamino)oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(butanoylamino)-3-hydroxytritriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)hexacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(decanoylamino)-3-hydroxyheptacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(heptanoylamino)-3-hydroxytriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tetracosanoylamino)tridec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(octacosanoylamino)non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]tridecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-octacos-17-enoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)dotriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
1-(9Z-hexadecenyl)-2-octadecanoyl-sn-glycero-3-phosphocholine
C42H84NO7P (745.5985083999999)
1-(11Z-octadecenyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine
C42H84NO7P (745.5985083999999)
1-eicosyl-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine
C42H84NO7P (745.5985083999999)
phosphatidylcholine O-34:1
C42H84NO7P (745.5985083999999)
A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 34 carbons and 1 double bond.
phosphatidylcholine (O-16:0/18:1)
C42H84NO7P (745.5985083999999)
A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine in which the acyl group contains 18 carbons and 1 double bond while the alkyl group contains 16 carbons and is fully saturated.
MePC(33:1)
C42H84NO7P (745.5985083999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LPC(34:1)
C42H84NO7P (745.5985083999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Hex1Cer(36:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved